Co-Diagnostics, Inc. CODX
0.13 USD -0.04 (-21.32%)
Regular-session close
0.14 +0.01 +5.95%
After hours · Nov 20, 7:41 PM ET
0.1276 Day range 0.1421
0.1295 52-week range 11.61
- YTD
- -97.45%
- 1 year
- -98.66%
CODX revenue history
Revenue is income from the company’s ordinary business activities.
622,489 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 622,489 | -3,292,671 | -84.10% |
| FY 2024 | 2024-12-31 | 3,915,160 | -2,896,878 | -42.53% |
| FY 2023 | 2023-12-31 | 6,812,038 | -27,406,171 | -80.09% |
| FY 2022 | 2022-12-31 | 34,218,209 | -63,667,394 | -65.04% |
| FY 2021 | 2021-12-31 | 97,885,603 | 23,332,845 | 31.30% |
| FY 2020 | 2020-12-31 | 74,552,758 | 74,337,784 | 34579.90% |
| FY 2019 | 2019-12-31 | 214,974 | 175,063 | 438.63% |
| FY 2018 | 2018-12-31 | 39,911 | 32,249 | 420.90% |
| FY 2017 | 2017-12-31 | 7,662 | 7,662 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | -10,000 | -100.00% |
| FY 2015 | 2015-12-31 | 10,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:35.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
